Career briefs, March 3

Mar. 02, 2014 @ 06:23 PM

Allen Tate announces February training graduates

DURHAM – Sarah Gabbert and Stewart Johnson from Chapel Hill and Durham were announced as Allen Tate Realtors’ “Winners Edge” real estate training program graduates.

The required, comprehensive real estate training program includes the latest in national real estate trends, technology, license law and sales and marketing techniques, integrated with detailed information about the local real estate market.

Durham dentist receives award

DURHAM -- The Academy of General Dentistry has announced that dentist Ellis K. List of Durham received the association’s Mastership Award during the AGD 2013 annual meeting and exhibits, held from June 27-30 in Nashville, Tenn. 

The award is the highest academy honor available, according to a news release. To earn the award, List had to complete a minimum of 1,100 hours of continuing dental education in 16 dental disciplines. List actually completed more than 1,800 hours.

As a Mastership Award recipient, List joins more than 2,300 active nationwide recipients. List is the first dentist in Durham to achieve the award, the release states, and is one of 43 practicing general dentists in North Carolina – eight in the Triangle -- to hold it.

List will working toward achieving the Lifelong Learning and Service Recognition after an additional 500 hours of learning, with 100 hours being volunteer service.

List graduated from Ohio State University School of Dentistry in 1987 and practices in Durham. 

Dignify Therapeutics appoints CEO

 DURHAM –Dignify Therapeutics, a Triangle-based drug development company focused on restoring bladder and bowel control to people with spinal injury, spina bifida and other neurological conditions, announced that Benny Ward has been appointed chief executive officer and board member.  

Ward has executive experience in several life science companies. Most recently, he  served as executive vice president for strategy and business development at BioDelivery Sciences International, a specialty pharmaceutical company focused on pain and addiction medicine. 

He spent almost 10 years as a member of the executive team of Closure Medical Corp., a biomaterials company acquired by Johnson and Johnson in 2005. 

He joined Closure prior to its initial public offering and was vice president of finance and chief financial officer at the time of the acquisition. 

From 2006 through 2008, Ward was a member of the senior management team, serving as vice president of finance and chief financial officer, of InnerPulse Inc., a development stage, venture-capital-funded, cardiac rhythm management company.